Corrigendum to "Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type" [Cancer Lett. 632 (2025) 217971].
Saved in:
| Title: | Corrigendum to "Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type" [Cancer Lett. 632 (2025) 217971]. |
|---|---|
| Authors: | Corre E; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Alard A; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Marbœuf C; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Lasfargues C; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Dailhau S; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France., Gilbert N; IRMB, Université de Montpellier, INSERM, Montpellier, France., Blum Y; Univ Rennes, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes), UMR-6290, ERL-U1305, 35000, Rennes, France., Nicolle R; Univ Paris Cité, CNRS, INSERM, CRI (Centre de Recherche sur l'Inflammation), UMR-1149, ERL-8252, 75018, Paris, France., Iovanna J; Univ Aix-Marseille, CNRS, INSERM, CRCM (Cancer Research Center of Marseille, UMR-1068, UMR-7258, Institut Paoli-Calmettes, 13288 Marseille, France., Dusetti N; Univ Aix-Marseille, CNRS, INSERM, CRCM (Cancer Research Center of Marseille, UMR-1068, UMR-7258, Institut Paoli-Calmettes, 13288 Marseille, France., Pyronnet S; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France. Electronic address: stephane.pyronnet@inserm.fr. |
| Source: | Cancer letters [Cancer Lett] 2026 Feb 28; Vol. 639, pp. 218202. Date of Electronic Publication: 2025 Dec 04. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41344967 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Corrigendum to "Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type" [Cancer Lett. 632 (2025) 217971]. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Corre+E%22">Corre E</searchLink>; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Alard+A%22">Alard A</searchLink>; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Marbœuf+C%22">Marbœuf C</searchLink>; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Lasfargues+C%22">Lasfargues C</searchLink>; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Dailhau+S%22">Dailhau S</searchLink>; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Gilbert+N%22">Gilbert N</searchLink>; IRMB, Université de Montpellier, INSERM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Blum+Y%22">Blum Y</searchLink>; Univ Rennes, CNRS, INSERM, IGDR (Institut de Génétique et Développement de Rennes), UMR-6290, ERL-U1305, 35000, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Nicolle+R%22">Nicolle R</searchLink>; Univ Paris Cité, CNRS, INSERM, CRI (Centre de Recherche sur l'Inflammation), UMR-1149, ERL-8252, 75018, Paris, France.<br /><searchLink fieldCode="AU" term="%22Iovanna+J%22">Iovanna J</searchLink>; Univ Aix-Marseille, CNRS, INSERM, CRCM (Cancer Research Center of Marseille, UMR-1068, UMR-7258, Institut Paoli-Calmettes, 13288 Marseille, France.<br /><searchLink fieldCode="AU" term="%22Dusetti+N%22">Dusetti N</searchLink>; Univ Aix-Marseille, CNRS, INSERM, CRCM (Cancer Research Center of Marseille, UMR-1068, UMR-7258, Institut Paoli-Calmettes, 13288 Marseille, France.<br /><searchLink fieldCode="AU" term="%22Pyronnet+S%22">Pyronnet S</searchLink>; Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Laboratoire d'Excellence Toulouse Cancer (Labex TOUCAN), Institut Universitaire du Cancer, 31037, Toulouse, France. Electronic address: stephane.pyronnet@inserm.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227600053%22">Cancer letters</searchLink> [Cancer Lett] 2026 Feb 28; Vol. 639, pp. 218202. <i>Date of Electronic Publication: </i>2025 Dec 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ireland%22">Elsevier Science Ireland </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>7600053 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203043835%22">03043835 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Lett <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41344967 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.canlet.2025.218202 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 218202 Titles: – TitleFull: Corrigendum to "Bimodal silencing of the acinar cell-specific mRNA translation repressor PAIP2B defines a poor prognostic subgroup within the classical pancreatic tumor type" [Cancer Lett. 632 (2025) 217971]. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Corre E – PersonEntity: Name: NameFull: Alard A – PersonEntity: Name: NameFull: Marbœuf C – PersonEntity: Name: NameFull: Lasfargues C – PersonEntity: Name: NameFull: Dailhau S – PersonEntity: Name: NameFull: Gilbert N – PersonEntity: Name: NameFull: Blum Y – PersonEntity: Name: NameFull: Nicolle R – PersonEntity: Name: NameFull: Iovanna J – PersonEntity: Name: NameFull: Dusetti N – PersonEntity: Name: NameFull: Pyronnet S IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 02 Text: 2026 Feb 28 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1872-7980 Numbering: – Type: volume Value: 639 Titles: – TitleFull: Cancer letters Type: main |
| ResultId | 1 |